Philippines is heating up, Canada and Brazil are progressing. Long Hauler COVID study anecdotal evidence is popping up and is sounding promising.- HIV combo therapy application is progressing and Leronlimab appears superior to the current HIV SOC with monotherapy a likely add on for the $20-30 billion market. Cancer is promising. This drug clearly works.